-
levonorgestrel, norethisterone
- lower risk of VTE
- listed on PBS
- widely used
- Levonorgestrel (100mcg):
- Loette, microgynon, microlevlen, monofeme, nordette
- triphasic: logynon, trifeme, triphasil, triquilar
- Norethisterone (150mcg):
- brevinor, norimin
- triphasic: improvil, synphasic
-
gestodene, desogestrel
- less androgenic activity
- double risk of VTE vs. levonorgestrel and norethisterone
- gestodene (75mcg): femoden, minulet
- desogestrel (150mcg): marvelon
-
dienogest
- anti-androgenic activity (approx 1/3 of cyproterone)
- beneficial effects on acne
- valette - 2mg, Qliara - 2mg/3mg
-
drospirenone
- related to spironolactone, anti-mineralocorticoid (mild diuretic and K+ retention) and anti-androgenic activity
- slightly higher risk of VTE than levonorgestrel
- Yaz, yasmin - 3mg
-
cyproterone
- progestogenic and anti-androgenic
- tx for androgenisation (severe acne, idiopathic hirsutism)
- higher incidence of VTE
- brenda-35, juliet-35, estelle-35, diane-35, laila-35 - 2mg
|
|
